Cargando…
Optimizing the corticosteroid dose in steroid-sensitive nephrotic syndrome
The use of corticosteroids in the treatment of steroid-sensitive nephrotic (SSNS) syndrome in children has evolved surprisingly slowly since the ISKDC consensus over 50 years ago. From a move towards longer courses of corticosteroid to treat the first episode in the 1990s and 2000s, more recent larg...
Autores principales: | Christian, Martin T., Maxted, Andrew P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896825/ https://www.ncbi.nlm.nih.gov/pubmed/33611671 http://dx.doi.org/10.1007/s00467-021-04985-1 |
Ejemplares similares
-
An updated view of the pathogenesis of steroid-sensitive nephrotic syndrome
por: Horinouchi, Tomoko, et al.
Publicado: (2022) -
Low-dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome
por: Maxted, Andrew P., et al.
Publicado: (2018) -
Steroid Sensitive Nephrotic Syndrome: Revised Guidelines
por: Sinha, Aditi, et al.
Publicado: (2021) -
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
por: Iijima, Kazumoto, et al.
Publicado: (2017) -
Revised guidelines for management of steroid-sensitive nephrotic syndrome
por: Bagga, Arvind
Publicado: (2008)